David Blanco
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Cancer-related gene regulation
Papers in
-
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 2
- Prostate Cancer Treatment and Research 1
- Co-authors
- Luis M. Montuenga (13 shared papers)Manel Esteller (3 shared papers)Amaia Lujambio (2 shared papers)Montse Sánchez‐Céspedes (1 shared paper)Carlo M. Croce (1 shared paper)Santiago Ropero (1 shared paper)William J. Faller (1 shared paper)Milena S. Nicoloso (1 shared paper)
- Journals
- PLoS ONE (2 papers)Laboratory Investigation (2 papers)Neoplasia (2 papers)European Radiology (2 papers)Inflammatory Bowel Diseases (1 paper)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
David Blanco
17 papers receiving 1.4k citations
David Blanco's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 710
- Molecular Biology 942
- Oncology 125
- Pulmonary and Respiratory Medicine 135
- Immunology 59
Countries citing papers authored by David Blanco
This map shows the geographic impact of David Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Blanco more than expected).
Fields of papers citing papers by David Blanco
This network shows the impact of papers produced by David Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Blanco. The network helps show where David Blanco may publish in the future.
Co-authors
The 25 scholars most cited alongside David Blanco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A microRNA DNA methylation signature for human cancer metastasis Hit paper breakdown → | 2008 | 905 |
| 2 | 2007 | 82 | |
| 3 | 2004 | 65 | |
| 4 | 2012 | 49 | |
| 5 | 2008 | 44 | |
| 6 | 2010 | 37 | |
| 7 | 2010 | 36 | |
| 8 | 2013 | 34 | |
| 9 | 2009 | 31 | |
| 10 | 2016 | 29 | |
| 11 | 2010 | 25 | |
| 12 | 2001 | 15 | |
| 13 | 2019 | 15 | |
| 14 | 2013 | 10 | |
| 15 | 2010 | 9 | |
| 16 | 2013 | 9 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 0 |
About David Blanco
David Blanco is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Cancer Research, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Research and Splicing (3 papers), Cancer-related molecular mechanisms research (3 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Inflammatory Bowel Disease (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Genetics and Neurodevelopmental Disorders (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (710 citations), Molecular Biology (942 citations), Oncology (125 citations), Pulmonary and Respiratory Medicine (135 citations) and Immunology (59 citations). David Blanco has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Luis M. Montuenga, Manel Esteller, Amaia Lujambio, Montse Sánchez‐Céspedes, Carlo M. Croce, Santiago Ropero, William J. Faller, Milena S. Nicoloso, William M. Gallagher and Simona Rossi. Their work appears in journals such as PLoS ONE, Laboratory Investigation, Neoplasia, European Radiology and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.